Detalhe da pesquisa
1.
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis.
Breast Cancer Res Treat
; 199(2): 389-397, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37002487
2.
Integrating Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Practical Evidence-Based Considerations.
J Natl Compr Canc Netw
; 20(7): 738-744, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830893
3.
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapy.
Support Care Cancer
; 30(8): 6613-6622, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488902
4.
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer.
Breast Cancer Res Treat
; 186(2): 561-568, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185832
5.
Extended Endocrine Therapy for Early-Stage Breast Cancer: How Do We Decide?
Curr Oncol Rep
; 22(12): 123, 2020 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015752
6.
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
Breast Cancer Res Treat
; 176(1): 95-100, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30977026
7.
Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer.
Qual Life Res
; 28(12): 3333-3346, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493269
8.
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.
Breast Cancer Res Treat
; 171(2): 371-381, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29850984
9.
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
Breast Cancer Res Treat
; 171(1): 121-129, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752687
10.
Immune Checkpoint Inhibitor Therapy in Breast Cancer.
J Natl Compr Canc Netw
; 16(10): 1259-1268, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323094
11.
Call for action: expanding global access to hereditary cancer genetic testing.
Lancet Oncol
; 23(9): 1124-1126, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055301
12.
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
Breast Cancer Res Treat
; 166(1): 179-184, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28752189
13.
Bi-level Graph Learning Unveils Prognosis-Relevant Tumor Microenvironment Patterns from Breast Multiplexed Digital Pathology.
bioRxiv
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712207
14.
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.
bioRxiv
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38826266
15.
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 10(2): 193-201, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095878
16.
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.
Cancer Discov
; 14(2): 290-307, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791898
17.
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.
Cancer Res Commun
; 4(4): 1120-1134, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687247
18.
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition.
Sci Adv
; 9(26): eadg0289, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390206
19.
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer.
bioRxiv
; 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187696
20.
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases.
Clin Breast Cancer
; 23(3): 324-329, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621430